Research Article| Volume 164, ISSUE 1-2, P87-88, October 28, 2011

Download started.


Seropositive myasthenia and autoimmune autonomic ganglionopathy: Cross reactivity or subclinical disease?


      Autoimmune autonomic ganglionopathy (AAG) and myasthenia gravis (MG) are both autoimmune channelopathies mediated by antibodies directed against nicotinic acetylcholine receptors. While both diseases target acetylcholine receptors, skeletal muscle and ganglionic receptor subtypes have key immunologic and genetic distinctions, and reports of patients with both AAG and MG are rare. We report a patient with antibody-confirmed AAG and elevated levels of ACh binding antibodies that did not meet clinical or electrodiagnostic criteria for MG. We presume that his skeletal muscle nAChR seropositivity was a false positive, perhaps due to the cross reactivity of the patient's ganglionic nAChR antibodies with skeletal nAChR subtypes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Autonomic Neuroscience: Basic and Clinical
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Anderson N.E.
        • et al.
        Intestinal pseudo-obstruction, myasthenia gravis, and thymoma.
        Neurology. 1996; 47: 985-987
        • Berger A.R.
        • et al.
        Myasthenia gravis presenting as uncontrollable flatus and urinary/fecal incontinence.
        Muscle Nerve. 1996; 19: 113-114
        • Cuenod S.
        • et al.
        Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
        Neurology. 1980; 30: 201-202
        • Drachman D.
        Myasthenia gravis.
        N. Engl. J. Med. 1994; 330: 1797-1810
        • Lieberman J.A.
        • et al.
        Antibodies to acetylcholine receptors in tardive dyskinesia.
        Lancet. 1984; 1: 1066
        • Lennon V.
        • et al.
        Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.
        J. Clin. Invest. 2003; 111: 907-913
        • Martin V.M.
        • et al.
        Anti-acetylcholine receptor antibodies in penicillamine treated patients without myasthenia.
        Lancet. 1980; 2: 705
        • McKeon A.
        • et al.
        Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.
        Arch. Neurol. 2009; 66: 735-741
        • Mittag T.W.
        • Caroscio J.
        False positive immunoassay for acetylcholine antibody in amyotrophic lateral sclerosis.
        N. Engl. J. Med. 1980; 302: 868
        • Peltier
        • et al.
        Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer.
        Muscle Nerve. 2010; 41: 416-419
        • Rakocevic G.
        • et al.
        Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review.
        J. Clin. Neuromuscul. Dis. 2003; 5: 93-95
        • Tabbaa M.A.
        • Leshner R.T.
        • Campbell W.W.
        Malignant thymoma with dysautonomia and disordered neuromuscular transmission.
        Arch. Neurol. 1986; 43: 955-957
        • Tan C.K.
        • et al.
        Acute intestinal pseudo-obstruction due to malignant thymoma.
        Singapore Med. J. 1993; 34: 175-178
        • Suarez
        • et al.
        Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients.
        Neurology. 1994; 44: 1675-1682
        • Vernino S.
        Neuronal acetycholine receptor autoimmunity.
        Ann. N. Y. Acad. Sci. 2008; 1132: 124-128
        • Vernino
        • et al.
        Characterization of ganglionic acetylcholine receptor autoantibodies.
        J. Neuroimmunol. 2008; 197: 63-69
        • Vernino
        • et al.
        Experimental acetylcholine receptor autoimmunity: coexisting myasthenia and autonomic failure.
        Neuromuscul. Disord. 2006; 16: S180
        • Vernino
        • et al.
        Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.
        N. Engl. J. Med. 2000; 343: 847-855
        • Vernino
        • et al.
        Myasthenia gravis with autoimmune autonomic neuropathy.
        Auton. Neurosci. 2001; 88: 187-192